Aim: There is a lack of studies on the prevalence of frailty, and the association between frailty and mortality in a Norwegian general population. Findings regarding sex differences in the association between frailty and mortality have been inconsistent. The aim of the present study was to investigate the association between the frailty phenotype and all-cause mortality in men and women in a Norwegian cohort study.
Introduction
A challenging manifestation of the aging population is the clinical condition of frailty. 1 Although there is no universal definition, frailty is, with growing consensus, considered a "syndrome of decreased reserve and resistance to stressors" 2 following an agerelated accumulative degeneration of several physiological systems and leading to a state of increased risk of adverse health outcomes, such as falls, disability, institutionalization and mortality. [1] [2] [3] [4] For frail individuals, this implies that stressors, such as changes in medication use or minor illnesses, can lead to a drastic decline in health. 1 The exact pathophysiology of frailty is still uncertain, but is thought to be a multifactorial interaction of physiology, lifestyle, environment, genes and disease. 5 Even though there is no gold standard for an operational definition, one of the most frequently used approaches is the frailty phenotype suggested by Fried et al. in 2001 , which defines frailty as the presence of three or more of the following characteristics: unintentional weight loss, low grip strength, exhaustion, low walking speed and low physical activity. 2 The association between the presence of frailty and an increased risk of mortality has been described before, but there is a lack of studies on the prevalence of frailty, and the association between frailty and mortality in a Norwegian general population. 2, [6] [7] [8] Furthermore, previous studies showed inconsistent results regarding sex differences in this association. [8] [9] [10] [11] The aim of the present study is to investigate the association between the frailty phenotype and all-cause mortality among community-dwelling men and women aged ≥70 years in a Norwegian population-based study.
Methods

Sample
The Tromsø Study is a population-based study in the Tromsø municipality consisting of seven surveys carried out between 1974 and 2016 (Tromsø 1-7), to which total birth cohorts and random samples of the population were invited (participation rates 65-79%). A total of 40 051 women and men participated in one or more surveys. Data collection consisted of questionnaires, biological sampling and clinical examinations. In Tromsø 4-7, a predefined group was invited to a second, more extensive clinical examination after attending the first visit. 12, 13 Participants in the second examination of Tromsø 4 and additional samples in the age groups 30, 40, 45, 60 and 75 years were eligible for invitation to Tromsø 5 (2001 Tromsø 5 ( -2002 . A total of 10 353 women and men were invited and 8130 (79%) attended. 12 Questionnaires for participants aged ≥70 years included all covariates of interest for the present analysis. Therefore, our sample included participants from Tromsø 5 aged ≥70 years (n = 2131, participation rate 83%). We excluded individuals with incomplete data for the frailty definition (n = 1419), leaving 712 participants (52% women) aged 70-87 years for analysis (Fig 1) . Norway has a unique personal identification system that allows exact matching of population register data. The Tromsø Study participant list was linked to the Norwegian Cause of Death Registry and the participants were followed until 1 January 2016, death or emigration, whichever came first. None of the included participants emigrated from Norway during follow-up; that is, mortality followup was complete.
The Regional Committee of Medical and Health Research Ethics and the Norwegian Data Protection Authority have approved the Tromsø Study, and all procedures were carried out in accordance with the 1964 Helsinki declaration and its later amendments. The participants gave written informed consent.
Frailty measurement
A modified version of the frailty phenotype by Fried et al. was used to identify frailty based on exhaustion, grip strength, walking speed and physical activity level. 2 Information about unintentional weight loss was unavailable. All single frailty markers were dichotomized. Participants with a score of 0 on all frailty markers were considered non-frail, those with 1 or 2 as pre-frail and those with ≥3 present frailty markers were considered frail.
Exhaustion was defined through one item from the Hopkins Symptom Checklist 10: "During the last week, have you experienced that everything is a struggle?". Participants reporting one of the highest two ("pretty much" or "very much") of four categories were considered exhausted. Physical activity level was defined by the self-reported weekly average of light (not sweating/out of breath) and hard (sweating/out of breath) leisure time physical activity, where 0 weekly hours in light and hard physical activity were considered low physical activity. Walking speed was assessed by the Timed Up and Go test (time for the participant to rise from a chair, walk 3 m, turn around, walk back to the chair and sit down 14, 15 ). The participants were instructed to carry out the test with footwear and could use the chair's armrests as support, if required. The cut-off for low walking speed was set to 15 s, which is the middle ground of various suggested cut-points, 16, 17 and has previously been shown to be the preferred threshold for the prediction of falls. 15 Grip strength was measured using a Martin vigorimeter (bar). The participants were allowed two attempts, and were instructed not to support their arm against anything and to use their non-dominant hand. The results were divided into five centiles adjusted for sex and body mass index; group (≤24, 24.1-26, 26.1-28 and >28). The lowest centile (the weakest 20%) was considered low grip strength in accordance with the suggestion from Fried et al., 2 and has previously been shown to have high agreement with population-independent cut-points for the Fried criteria. 18 A comparison of the frailty definition in the present study and the original Fried criteria is presented in the supporting information (Table S1 ).
Covariates
Age was included as a continuous variable. Self-reported smoking status was dichotomized into current daily smoking or non-smoking at baseline. Years of education were grouped into primary school (7 years), high school (8-12 years) and college/university (≥13 years). Comorbidity was defined through self-report (previous and/or current disease) of two or more of the following diseases at baseline: pulmonary disease (asthma/chronic bronchitis/emphysema), cancer, diabetes, stroke, coronary heart disease (angina pectoris and/or heart attack) and peptic ulcer, based on the Charlson Comorbidity Index without weighting of diseases. 19 Disability was defined as difficulties in carrying out everyday activities as a result of chronic health problems (mobility inside own home, moving out of home without assistance, participation in leisure-time activities, using public transport or carrying out necessary daily errands). Participants reporting some or great difficulties in one or more daily activities were classified as disabled.
Statistical analysis
Baseline characteristics are presented as frequencies and mean values stratified by frailty status (Table 1) , sex (Table S2 ) and completeness of frailty data (Table S3 ). Statistical differences were tested with χ 2 -tests for categorical variables and the t-test or linear regression for continuous variables. Frequencies of single frailty markers stratified by sex at baseline are presented in Table 2 . Cox regression was used to calculate hazard ratios (HR) with 95% confidence intervals (CI) for analysis of the association between frailty status at baseline and all-cause mortality (Table 3 ; Fig. 2 ). In accordance with Fried et al., the time from study entry up until the day of death or the end of the study -whichever came first -was used as the time-scale. 2 The log-log plot and Schoenfeld residuals were examined for the total sample, and for men and women separately. No violation of the proportional hazards assumption was detected. Three regression models were run for women and men, combined and separately. The first model included the whole sample, the second a reduced sample with complete data for all covariates and both models adjusted for age (and sex for women and men combined). The third model additionally adjusted for disability, comorbidity, smoking and education. As a sensitivity analysis, the third model was run again in a sample with multiple imputed missing data among the covariates (Table S4) . A possible interaction between sex and frailty status was investigated by adding interaction terms in the regression analysis. All analyses were carried out using Stata 14.2 (StataCorp LLP, College Station, TX, USA). A P-value of <0.05 was regarded as statistically significant.
Results
The mean age was 77.4 (SD AE 2.4, range 70-87 years), with a majority of participants being aged 74-81 years (n = 686). In total, 3.8% (n = 27) were defined as frail and 38.1% (n = 271) as prefrail. Among women, 4.4% were frail and 45.8% were pre-frail. Among men, 3.2% were frail and 29.9% were pre-frail. Frail participants differed from pre-frail and non-frail participants (Table 1) ; with increasing frailty status, participants were more likely to be older, female and to have a shorter length of education. There was a stepwise increase in comorbidity and disability with increasing frailty status. Among the frail individuals, 91.7% reported disability (92.3% of women, 90.9% of men) and 61.9% reported comorbidity (64.3% of women, 57.1% of men). Table 2 shows the prevalence of each frailty marker. Out of the 712 participants, 501 (70.4%) died during followup (226 women [61.6%] and 275 men [79.7%]). Women had a median survival of 12.5 years, whereas half of the men had died after 9.7 years. Among the frail, the median survival time was 5.9 and 2.8 years for women and men, respectively. Figure 2 shows the age-adjusted survival curves based on the Cox model for women and men according to their frailty status at baseline. Including angina pectoris and/or heart attack. BMI, body mass index; CHD, coronary heart disease; SMC, subjective memory complaint. Adjusted for age and sex (model 2), frail participants had a 5.96-fold higher risk of death (95% CI 3.58-9.93) compared with non-frail participants (Table 3) . After further adjustment for disability, comorbidity, smoking and education, the hazard ratio dropped to 4.16 (95% CI 2.40-7.22). When the analysis was stratified by sex, frail women had a 4.53 higher risk of death compared with those who were not frail (95% CI 2.34-8.78) in the ageadjusted model. After further covariate adjustment, the risk of death was attenuated, but remained statistically significant (HR 2.93, 95% CI 1.38-6.22). For frail men, the risk of death was 8.55-fold higher compared with those who were not frail when adjusted for age (95% CI 3.84-19.03), and 7.09-fold higher in the multivariable-adjusted model (95% CI 3.03-16.58). Pre-frailty was also associated with all-cause mortality (HR 1.50, 95% CI 1.18-1.91) relative to non-frailty after multivariable adjustment. In sex-stratified analysis, pre-frailty was significantly associated with mortality in men, but not in women. In the multivariable-adjusted model, there was a significant interaction (P = 0.046) between sex and frailty. Using multiple imputation attenuated the results slightly, but the conclusions remained unaltered (Table S4 ).
Discussion
In the present prospective cohort study of 712 communitydwelling women and men aged ≥70 years, we found that frailty was significantly associated with increased all-cause mortality. This association was stronger in men than in women.
In accordance with the present findings, several previous studies showed higher frailty prevalence among women compared with men, 2, 6, 7, 20 an increase in frailty with increasing age, 2,6,9,20,21 as well as the general tendency of a higher prevalence of diseases and adverse socioeconomic and lifestyle-related factors among the frail.
2,20,21
The overlap of frailty with comorbidity in the present study (62%) is similar to that in the study by Fried et al. (68%) . 2 In the present study, a vast majority of those who were classified as frail also reported disability (92%). Fried et al. found that just 27% of the frail participants also reported difficulty in activities of daily living. 2 However, the findings in the present study are in accordance with studies challenging the assumption that disability and frailty only overlap modestly. Theou et al. examined the overlap of the frailty phenotype with disability in the Canadian Study of Health and Aging, and found that 84% of frail people also reported disability. 22 In an analysis from the National Health and Nutrition Examination Survey, as many as 98% of frail people aged ≥50 years had activities of daily living disability, suggesting that frailty might not be a pre-disability state. 23 These studies all vary in the way in which the criteria for the frailty phenotype were modified and how disability was measured, which can strongly influence the amount of overlap between the concepts. Nevertheless, the overlap in the present study also suggests that the frailty phenotype does not only identify participants at high risk of disability, but more specifically those being in an especially vulnerable state of disability. We found a strong association between frailty status and allcause mortality. Furthermore, the effect sizes and interaction analysis suggest that the association is stronger for men. This is in accordance with results from a systematic review using the frailty phenotype, which found a 2.66-fold increased mortality risk for frail men (95% CI 2.02-3.50) and 1.88 for frail women (95% CI 1.64-2.15) compared with non-frail individuals. 10 Equally, a study of Mexican Americans aged ≥65 years found a 3.04-fold higher mortality risk for frail men (95% CI 2.16-4.28) and 1.92-fold higher risk for frail women (95% CI 1.39-2.65) compared with those who were non-frail. 11 Theou et al. found an association between frailty and mortality that was statistically significant for both sexes, but stronger for men on seven different frailty scales. 24 Conversely, two USA studies using different frailty measures 7,9 and a Finnish study using the phenotype Table 3 Hazard ratios (95% confidence intervals) for all-cause mortality by frailty status at baseline in the Tromsø found a stronger association of frailty and mortality among women. 8 The finding of a higher frailty prevalence in women, but higher frailty-associated mortality in men, is in line with the Male-Female Health-Survival Paradox, which refers to the phenomenon that women have a higher rate of disability, diseases and worse selfreported health, but also greater longevity compared with men. 25 Women seem to be able to live longer with frailty, whereas men tend to die more suddenly. 7, 8 Women are also more likely to have a stronger social support system and to actively seek help when required compared with men, which could compensate for some of the risk associated with frailty. 10, 11 Volunteer bias and the absence of frailty measures affect the estimation of the true prevalence of the frailty phenotype and its association with mortality. Study participants tend to be healthier than non-attendees. 26 Non-attendance by the most ill individuals might have led to an underestimation of frailty prevalence and its association with mortality in the present study.
Participants excluded due to missing data on frailty criteria were younger, and comprised more women and current smokers compared with those with complete frailty data, but there were no significant differences in disease prevalence (Table S3) .
Estimates of frailty prevalence are tentative, as the identification of frailty is substantially influenced by varying definitions and modifications. 27, 28 In the present analysis, we used four of the five Fried criteria to detect frailty. If unintentional weight loss had been available for assessment, there might have been more individuals classified as frail or pre-frail, as suggested in a systematic review on modifications of the frailty phenotype where 4-item phenotype scales estimated lower prevalence than 5-item phenotypes. 28 The two self-reported frailty markers, exhaustion and physical activity level, might have been affected by information bias. A previous analysis from the Tromsø Study found that self-reported leisure time activity is over-reported in both men and women, but the degree of overestimation is greater among men. 29 A qualitative study from Spain on sex differences in the perception of health and vulnerability found that women tend to emphasize their exhaustion and report worse self-perceived health than men, whereas men tend to downplay their health problems. 30 Consequently, if men did report exhaustion and inactivity in this study, it might have signaled a higher severity than in women, meaning that the same frailty score for men and women would have been be more lethal for men. Most covariates were dichotomized in this analysis, which leads to loss of information and potential for unaccounted confounding. Comorbidity was assessed through self-report of current as well as previous diseases and did not include weighing for the severity of the disease. Furthermore, confounding of the association between frailty and mortality by the effect of single diseases is possible and might have led to an overestimation of the strength of association, given the higher disease prevalence among the frail.
The HR for frail participants in the present study are considerably larger than in most previous findings. These results have to be interpreted with caution because of the low number of frail people in the sample, which led to low precision of the effect estimates.
The vast majority of participants were aged 74 to 81 years, so the findings are most valid for this age group. Furthermore, the results should not be generalized to the population of older people living in nursing homes and the like, where the prevalence and severity of frailty is expected to be considerably higher than among community-dwelling individuals. 2, 27 Major strengths of the study were the high participation rate and the ascertainment of mortality status for every participant, resulting in complete follow-up.
A significant association between frailty and mortality was found in the present population-based study of 712 communitydwelling Norwegian women and men aged ≥70 years. Although frailty was more prevalent in women, the results suggest that the risk of death might be higher for frail men than for frail women. Continued efforts should be made to agree on universal definitions and measurements of frailty, in order to enable comparable research, and to provide a firm basis for potential prevention and intervention strategies.
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